Mikania lindleyana DC. (Asteraceae), popularly named sucuriju, is a common plant in Brazilian Amazonia. Ethnopharmacological studies show a diversity of uses of this species such in treatment of gastritis, infection, pain and inflammation. To validate the claim form and use was decided to study the acute toxicity and the antinociceptive and anti-inflammatory activities in experimental animal models and the chemical composition of lyophilized crude aqueous extract of Mikania lindleyana (AEML). The phytochemical screening of AEML showed the presence of saponins, proteins, amino acids, phenols, tannins, organic acids and flavonoids. On the thin layer chromatography (TLC) blues fluorescence characteristics of the coumaric acid were identifieds. The analisis on high-performance liquid chromatography coupled to mass spectrometry (HPLC-DAD-MS) seems compounds highly glycosylated. The dose 5000mg/kg of EAML did not cause death in animals. The AEML, at doses 125, 250, 500, 750, 1000 and 1500mg/kg, significantly inhibited (in a dose-dependant way) the number of contortions induced by acetic acid on writhing test. The median effective dose (ED50) of 692.6 mg/kg did not prolong the latency-time in the hot plate. The AEML showed activity in both first and second phase of formalin-induced licking response decreasing of the lick paw of mice, where this effect was reversed by the opioid antagonist naloxone. The AEML was able to inhibite the erythema formation when compared to control group, but did not inhibite the paw edema formation induced by dextran. The AEML inhibited the paw edema carrageenan-induced from 2nd hour and reduced neutrophil migration to peritoneal cavity. Our results indicate that AEML demonstrate an antinociceptive effect with probable involvement of the opioid system, and anti-inflammatory activity through inhibition of prodution of inflammatory mediators as PGs, and also on adhesion molecules with involvement of cytokines.
|
